We are live on ! Find out more
ACOR

Acorda Therapeutics
ACOR

Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

60 hedge funds and large institutions have $9.86M invested in Acorda Therapeutics in 2020 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 28 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% less funds holding

Funds holding: 79 → 60 (-19)

44% less capital invested

Capital invested by funds: $17.6M → $9.86M (-$7.75M)

64% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 28

83% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 23

87% less call options, than puts

Call options by funds: $103K | Put options by funds: $793K

Holders
60
Holders Change
-19
Holders Change %
-24.05%
% of All Funds
1.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
10
Reduced
28
Closed
23
Calls
$103K
Puts
$793K
Net Calls
-$690K
Net Calls Change
+$1.61M

Top Buyers

Rank Fund Capital Flow
1
Parallax Volatility Advisers
Parallax Volatility Advisers
California
+$894K
2
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$468K
3
GCP
GSA Capital Partners
United Kingdom
+$388K
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$80.3K
5
Citadel Advisors
Citadel Advisors
Florida
+$72.9K

Top Sellers

Rank Fund Capital Flow
1
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$925K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$720K
3
AQR Capital Management
AQR Capital Management
Connecticut
-$706K
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$464K
5
Millennium Management
Millennium Management
New York
-$389K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
51
Bank of America
North Carolina
$1K -$42.7K -566 -97%
Citigroup
52
Citigroup
New York
$1K -$1.36K -18 -62%
FWM
53
Focused Wealth Management
New York
$1K – – –
Osaic Holdings
54
Osaic Holdings
Arizona
$1K – – –
JP Morgan Chase
55
JP Morgan Chase
New York
$1K +$603 +8 +62%
TRCT
56
Tower Research Capital (TRC)
New York
$1K +$905 +12 New
Millennium Management
57
Millennium Management
New York
$16 -$389K -5,162 -95%
AQR Capital Management
58
AQR Capital Management
Connecticut
– -$706K -8,012 Closed
Fidelity Investments
59
Fidelity Investments
Massachusetts
– -$464K -5,264 Closed
Susquehanna International Group
60
Susquehanna International Group
Pennsylvania
– -$356K -4,723 Closed
Two Sigma Advisers
61
Two Sigma Advisers
New York
– -$355K -4,032 Closed
Jane Street
62
Jane Street
New York
– -$191K -2,167 Closed
PP
63
Paloma Partners
Connecticut
– -$175K -1,990 Closed
Two Sigma Investments
64
Two Sigma Investments
New York
– -$139K -1,574 Closed
Group One Trading
65
Group One Trading
Illinois
– -$55.1K -731 Closed
Capstone Investment Advisors
66
Capstone Investment Advisors
New York
– -$39K -444 Closed
ARTA
67
A.R.T. Advisors
New York
– -$20K -230 Closed
VF
68
Virtu Financial
New York
– -$20K -224 Closed
WAM
69
Wolverine Asset Management
Illinois
– -$16K -186 Closed
D.E. Shaw & Co
70
D.E. Shaw & Co
New York
– -$12K -137 Closed
ECM
71
ExodusPoint Capital Management
New York
– -$11K -128 Closed
AG
72
Aperio Group
California
– -$11K -122 Closed
LSERS
73
Louisiana State Employees Retirement System
Louisiana
– -$10K -110 Closed
Barclays
74
Barclays
United Kingdom
– -$9K -100 Closed
AWA
75
Arkadios Wealth Advisors
Georgia
– -$7K -83 Closed
1 2
3
4

ACOR Hedge Fund Activity: Q3 2020 in Review

60 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Acorda Therapeutics (ACOR) for Q3 2020, worth a combined $9.86M — down 44% from $17.6M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of ACOR and 4 opened new positions — a net loss of 19 holders — while 28 trimmed existing stakes and 10 added.

The largest buyer was Parallax Volatility Advisers, adding an estimated $894K. The largest seller was Dimensional Fund Advisors, cutting an estimated $925K.

  • 60 institutional investors held Acorda Therapeutics (ACOR) as of Q3 2020, down from 79 in Q2 2020.
  • Funds reported $9.86M of Acorda Therapeutics stock for Q3 2020, down 44% quarter-over-quarter.
  • 4 funds opened new Acorda Therapeutics positions in Q3 2020 and 23 closed out, a net change of -19 holders.
  • The largest Acorda Therapeutics buyer in Q3 2020 was Parallax Volatility Advisers, an estimated $894K added.
  • The largest Acorda Therapeutics seller in Q3 2020 was Dimensional Fund Advisors, an estimated $925K sold.

Based on aggregated 13F filings for Q3 2020.